Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “SION”

1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,496
Index total 30,257
Page 25 / 63

Quick answer

This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,496 results for “SION” · 30,257 patents in full index Clear search

  1. US 10364295

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  2. US 10363292

    Vaccination with anti-tick antigens to control multiple tick species and disease transmission in white-tailed deer and other host animals

    The United States of America, as represented by the Secretary of Agriculture · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  3. US 10364433

    Modulation of AGPAT5 expression

    The Regents of the University of California · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  4. US 10357217

    Method for positron emission tomography (PET) imaging analysis for classifying and diagnosing of neurological diseases

    The Regents of the University of California · Granted Jul 23, 2019 · Expires Jul 18, 2039

    granted

  5. US 10351628

    Antibody fragments, compositions and uses thereof

    METIS PRECISION MEDICINE SB S.R.L. · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted

  6. US 10351580

    Acene-based transmitter molecules for photon upconversion

    The Regents of the University of California · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted

  7. US 10351618

    UTI fusion proteins

    Takeda Pharmaceutical Company Limited · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted

  8. US 10342786

    P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD

    Fulcrum Therapeutics, Inc. · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  9. US 10327461

    Food thickening agent, method for producing food thickening agent

    Kent Precision Foods Group, Inc. · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted

  10. US 10322184

    Emulsions for intrapulmonary delivery

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted

  11. US 10314889

    Suppression of allergic lung inflammation and hyperreactivity

    The Regents of the University of California · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted

  12. US 10308941

    Compositions and methods for inhibiting gene expression of factor XII

    Arrowhead Pharmaceuticals, Inc. · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  13. US 10308934

    Compositions for modulating Ataxin 2 expression

    Ionis Pharmaceuticals, Inc. · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  14. US 10308720

    Multivalent and multispecific DR5-binding fusion proteins

    Inhibrx, Inc. · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  15. US 10301369

    Nucleic acids encoding targeted therapeutic lysosomal enzyme fusion proteins

    BIOMARIN PHARMACEUTICAL INC. · Granted May 28, 2019 · Expires May 23, 2039

    granted

  16. US 10294477

    Compositions and methods for modulating PKK expression

    Ionis Pharmaceuticals, Inc. · Granted May 21, 2019 · Expires May 16, 2039

    granted

  17. US 10285962

    Glutarate compounds for treating ischemia-reperfusion injuries

    The Regents of the University of California · Granted May 14, 2019 · Expires May 9, 2039

    granted

  18. US 10285940

    Multicomponent, internally structured nanoemulsions and methods of production

    The Regents of the University of California · Granted May 14, 2019 · Expires May 9, 2039

    granted

  19. US 10280423

    Compositions and methods for modulating complement factor B expression

    Ionis Pharmaceuticals, Inc. · Granted May 7, 2019 · Expires May 2, 2039

    granted

  20. US 10272184

    Hydrogel membrane for adhesion prevention

    The Board of Regents of the University of Texas System · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  21. US 10272137

    Compositions and methods relating to myomaker-induced muscle cell fusion

    The Board of Regents of the University of Texas System · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  22. US 10258612

    Mitochondrial lipid permeable iron chelators for treating and preventing ischemia/reperfusion (I/R) injury in the heart following an ischemic event

    Northwestern University · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  23. US 10251909

    Potassium-magnesium citrate as a surrogate of the DASH diet in managing hypertension

    The Board of Regents of the University of Texas System · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  24. US 10240152

    Compositions and methods for inhibiting expression of transthyretin

    Alnylam Pharmaceuticals, Inc. · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.